Given the involvement of HDACs in cognitive processes, HDAC inhibitors have emerged as potential therapeutic agents for cognitive disorders (Hamze, 2020; Melesina et al., 2021; Thomas et al., 2008). Here, HDAC9 is linked to Cognitive impairment.